Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 17, 2020, titled "Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets".
Press Release Oct 17 2020
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 16 2020
- Press Release Oct 08 2020
- Press Release Sep 25 2020
- Press Release Sep 24 2020
- Press Release Sep 18 2020
Later from Zydus Lifesciences
- Press Release Oct 19 2020
- Press Release Oct 20 2020
- Press Release Oct 23 2020
- Press Release Oct 29 2020
- Press Release Nov 02 2020
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences